| Ident. | Authors (with country if any) | Title |
|---|
| 000011 (2020) |
Binqing Fu ; Xiaoling Xu ; Haiming Wei | Why tocilizumab could be an effective treatment for severe COVID-19? |
| 000016 (2020) |
M. Silberstein | Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? |
| 000020 (2020) |
Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis] | Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report. |
| 000031 (2020) |
Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France] | Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab. |
| 000048 (2020) |
Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie] | Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. |
| 000052 (2020) |
Yasuhiko Hirabayashi [Japon] | Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis. |
| 000055 (2020) |
Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine] | Tocilizumab treatment in COVID-19: A single center experience. |
| 000061 (2020) |
Ver Nica Cantarín-Extremera [Espagne] ; María Jiménez-Legido [Espagne] ; Anna Duat-Rodríguez [Espagne] ; Marta García-Fernández [Espagne] ; Nelmar Valentina Ortiz-Cabrera [Espagne] ; María Luz Ruiz-Falc Rojas [Espagne] ; Luis González-Gutiérrez-Solana [Espagne] | Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients. |
| 000063 (2020) |
Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Tsutomu Takeuchi [Japon] | Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review. |
| 000090 (2020) |
Muneyoshi Futami [Japon] ; Keisuke Suzuki [Japon] ; Satomi Kato [Japon] ; Saori Ohmae [Japon] ; Yoshio Tahara [Japon] ; Masanori Nojima [Japon] ; Yoichi Imai [Japon] ; Takayuki Mimura [Japon] ; Yoshihiro Watanabe [Japon] ; Arinobu Tojo [Japon] | The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells. |
| 000095 (2020) |
Chi Zhang [République populaire de Chine] ; Zhao Wu [République populaire de Chine] ; Jia-Wen Li [République populaire de Chine] ; Hong Zhao [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine] | The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality |
| 000099 (2020) |
Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie] | The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 |
| 000118 (2020) |
Gregory S. Calip [États-Unis] ; Pritesh R. Patel [États-Unis] ; Karen Sweiss [États-Unis] ; Zhaoju Wu [États-Unis] ; Jifang Zhou [États-Unis] ; Alemseged A. Asfaw [États-Unis] ; Sruthi Adimadhyam [États-Unis] ; Todd A. Lee [États-Unis] ; Brian C-H Chiu [États-Unis] | Targets of biologic disease-modifying antirheumatic drugs and risk of multiple myeloma. |
| 000136 (2020) |
Gehan Elolemy [Koweït] ; Abdulrahman Al Rashidi [Koweït] ; Ahmed Dehrab [Koweït] ; Ammar Almathkouri [Koweït] ; Alex Varghese [Koweït] ; Mustafa Chikhly [Koweït] ; Fatema Alkhawaja [Koweït] | Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case report. |
| 000155 (2020) |
Meng Xu ; Congcong Liu ; Lishuang Guo ; Sirui Yang | Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report |
| 000159 (2020) |
Cem Gabay [Suisse] ; Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Toshio Kimura [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Susan H. Boklage [États-Unis] ; Jonathan Sadeh [États-Unis] ; Neil M. H. Graham [États-Unis] ; Anita Boyapati [États-Unis] | Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes |
| 000161 (2020) |
Shiyuan Wen [République populaire de Chine] ; Feng Wang [République populaire de Chine] ; Zhenhua Ji [République populaire de Chine] ; Yingyi Pan [République populaire de Chine] ; Miaomiao Jian [République populaire de Chine] ; Yunfeng Bi [République populaire de Chine] ; Guozhong Zhou [République populaire de Chine] ; Lisha Luo [République populaire de Chine] ; Taigui Chen [République populaire de Chine] ; Lianbao Li [République populaire de Chine] ; Zhe Ding [République populaire de Chine] ; Manzama-Esso Abi [République populaire de Chine] ; Aihua Liu [République populaire de Chine] ; Fukai Bao [République populaire de Chine] | Salp15, a Multifunctional Protein From Tick Saliva With Potential Pharmaceutical Effects |
| 000180 (2020) |
Emily Yi-Chih Ting ; Albert C. Yang [États-Unis] ; Shih-Jen Tsai [Taïwan] | Role of Interleukin-6 in Depressive Disorder |
| 000208 (2020) |
Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie] | Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration |
| 000256 (2020) |
Francesco Bennardo [Italie] ; Caterina Buffone [Italie] ; Amerigo Giudice [Italie] | New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. |
| 000279 (2020) |
Stefan Poschner ; Judith Wackerlig ; Dan Cacsire Castillo-Tong ; Andrea Wolf ; Isabel Von Der Decken ; Tea Lanišnik Rižner ; Renata Pavli ; Anastasia Meshcheryakova ; Diana Mechtcheriakova ; Monika Fritzer-Szekeres ; Theresia Thalhammer ; Walter J Ger [Autriche] | Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells |
| 000281 (2020) |
Haihua Zhang [République populaire de Chine] ; Tao Wang [République populaire de Chine] ; Zhifa Han [République populaire de Chine] ; Guiyou Liu [République populaire de Chine] | Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases. |
| 000297 (2020) |
Jie Xiao [République populaire de Chine] ; Tian Wang [République populaire de Chine] ; Yi Xu [République populaire de Chine] ; Xiaozhen Gu [République populaire de Chine] ; Danyang Li [République populaire de Chine] ; Kang Niu [République populaire de Chine] ; Tiandong Wang [République populaire de Chine] ; Jing Zhao [République populaire de Chine] ; Ruiqing Zhou [République populaire de Chine] ; Hui-Li Wang [République populaire de Chine] | Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats |
| 000301 (2020) |
Austin R. Morrison ; Joseph M. Johnson ; Mayur Ramesh ; Patrick Bradley ; Jeffery Jennings ; Zachary R. Smith | Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab. |
| 000310 (2020) |
Guoqiang Zhang [République populaire de Chine] ; Hayato Iwase [États-Unis] ; Liaoran Wang [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Abhijit Jagdale [États-Unis] ; David Ayares [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hidetaka Hara [États-Unis] | Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation? |
| 000311 (2020) |
Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde] | Is biological therapy in systemic sclerosis the answer? |
| 000312 (2020) |
Clara Camaschella [Italie] ; Antonella Nai [Italie] ; Laura Silvestri [Italie] | Iron metabolism and iron disorders revisited in the hepcidin era |
| 000318 (2020) |
Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne] | Interleukin-6: A Masterplayer in the Cytokine Network. |
| 000319 (2020) |
Paula Sanchis ; Olaya Fernández-Gayol [États-Unis] ; Gemma Comes ; Anna Escrig ; Mercedes Giralt ; Richard D. Palmiter ; Juan Hidalgo | Interleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner |
| 000320 (2020) |
Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. Grandis | Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance |
| 000331 (2020) |
Anne Y. Liu [États-Unis] | Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. |
| 000338 (2020) |
Ivan Arias De La Rosa [Espagne] ; Carlos Perez-Sanchez [Royaume-Uni] ; Patricia Ruiz-Limon [Espagne] ; Alejandra Pati O-Trives [Espagne] ; Carmen Torres-Granados [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Irene Cecchi [Italie] ; Rafaela Ortega [Espagne] ; Miguel Angel Caracuel [Espagne] ; Jerusalem Calvo-Gutierrez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Chary Lopez-Pedrera [Espagne] ; Nuria Barbarroja [Oman] | Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies. |
| 000341 (2020) |
Claas Hinze [Allemagne] ; Sabrina Fuehner [Allemagne] ; Christoph Kessel [Allemagne] ; Helmut Wittkowski [Allemagne] ; Elke Lainka [Allemagne] ; Melanie Baehr [Allemagne] ; Boris Hügle [Allemagne] ; Johannes-Peter Haas [Allemagne] ; Gerd Ganser [Allemagne] ; Elisabeth Wei Barth-Riedel [Allemagne] ; Annette Jansson [Allemagne] ; Dirk Foell [Allemagne] | Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis. |
| 000359 (2020) |
Yanyan Han ; Takuro Igawa ; Kyohei Ogino ; Asami Nishikori ; Yuka Gion ; Tadashi Yoshino ; Yasuharu Sato | Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease |
| 000373 (2020) |
Hongzhuan Xuan [République populaire de Chine] ; Aiqun Ou ; Shengyu Hao ; Jiajun Shi ; Xiaolu Jin [République populaire de Chine] | Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota |
| 000374 (2020) |
Tolu Omokehinde [États-Unis] ; Rachelle W. Johnson [États-Unis] | GP130 Cytokines in Breast Cancer and Bone |
| 000387 (2020) |
Jeffrey P. Jacobs [États-Unis] ; Alfred H. Stammers [États-Unis] ; James St Louis [États-Unis] ; J W Awori Hayanga [États-Unis] ; Michael S. Firstenberg [États-Unis] ; Linda B. Mongero [États-Unis] ; Eric A. Tesdahl [États-Unis] ; Keshava Rajagopal [États-Unis] ; Faisal H. Cheema [États-Unis] ; Tom Coley [États-Unis] ; Vinay Badhwar [États-Unis] ; Anthony K. Sestokas [États-Unis] ; Marvin J. Slepian [États-Unis] | Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. |
| 000389 (2020) |
Koichi Nakamura ; Tomoki Nakamura ; Takahiro Iino ; Tomohito Hagi ; Kouji Kita ; Kunihiro Asanuma ; Akihiro Sudo | Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas |
| 000400 (2020) |
Muhammad Aziz [États-Unis] ; Rawish Fatima [États-Unis] ; Ragheb Assaly [États-Unis] | Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis. |
| 000403 (2020) |
Hiroki Hoshino [Japon] ; Yoko Shirai [Japon] ; Hiroe Konishi [Japon] ; Takashi Yamamura [Japon] ; Norikazu Shimizu [Japon] | Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy. |
| 000411 (2020) |
Lutz Wollin [Allemagne] ; Dieudonnée Togbe [France] ; Bernhard Ryffel [France] | Effects of Nintedanib in an Animal Model of Liver Fibrosis |
| 000419 (2020) |
Xiaoling Xu [République populaire de Chine] ; Mingfeng Han [République populaire de Chine] ; Tiantian Li [République populaire de Chine] ; Wei Sun [République populaire de Chine] ; Dongsheng Wang [République populaire de Chine] ; Binqing Fu [République populaire de Chine] ; Yonggang Zhou [République populaire de Chine] ; Xiaohu Zheng [République populaire de Chine] ; Yun Yang [République populaire de Chine] ; Xiuyong Li [République populaire de Chine] ; Xiaohua Zhang [République populaire de Chine] ; Aijun Pan [République populaire de Chine] ; Haiming Wei [République populaire de Chine] | Effective treatment of severe COVID-19 patients with tocilizumab. |
| 000462 (2020) |
Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert Rübben | Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer |
| 000463 (2020) |
John D. Koerner [États-Unis] ; Dessislava Z. Markova [États-Unis] ; Greg D. Schroeder [États-Unis] ; Christopher L. Antonacci [États-Unis] ; Joseph Mendelis [États-Unis] ; Alexander R. Vaccaro [États-Unis] ; D. Greg Anderson [États-Unis] ; Chris K. Kepler [États-Unis] | Correlation of Early Outcomes and Intradiscal Interleukin-6 Expression in Lumbar Fusion Patients |
| 000483 (2020) |
Antonio Vitale [Italie] ; Giulio Cavalli [Italie] ; Piero Ruscitti [Italie] ; Jurgen Sota [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Maria Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Elena Cavallaro [Italie] ; Maria Grazia Massaro [Italie] ; Paola Cipriani [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Micol Frassi [Italie] ; Roberto Gerli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Marco Fornaro [Italie] ; Anna Paladini [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Bruno Frediani [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Donato Rigante [Italie] ; Lorenzo Dagna [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie] | Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes |
| 000497 (2020) |
Satoshi Tsukuda [Japon] ; Tsukasa Ikeura [Japon] ; Takashi Ito [Japon] ; Koh Nakamaru [Japon] ; Masataka Masuda [Japon] ; Yuichi Hori [Japon] ; Manami Ikemune [Japon] ; Masato Yanagawa [Japon] ; Toshihiro Tanaka [Japon] ; Takashi Tomiyama [Japon] ; Takashi Yamaguchi [Japon] ; Yugo Ando [Japon] ; Kazushige Uchida [Japon] ; Toshiro Fukui [Japon] ; Akiyoshi Nishio [Japon] ; Rika Terasawa [Japon] ; Noboru Tanigawa [Japon] ; Kazuichi Okazaki [Japon] | Clinical implications of elevated serum interleukin-6 in IgG4-related disease |
| 000525 (2020) |
Bingwen Liu [République populaire de Chine] ; Min Li [République populaire de Chine] ; Zhiguang Zhou [République populaire de Chine] ; Xuan Guan [États-Unis] ; Yufei Xiang [République populaire de Chine] | Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? |
| 000552 (2020) |
Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] | COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. |
| 000579 (2020) |
Levent Kiliç [Turquie] ; Ömer Karada [Turquie] ; Abdulsamet Erden [Turquie] ; Alper Sari [Turquie] ; Berkan Arma An [Turquie] ; Gözde Kübra Yardimci [Turquie] ; Esra Firat [Turquie] ; Umut Kalyoncu [Turquie] ; Ule Apra B Lgen [Turquie] ; Sedat K Raz [Turquie] ; Hsan Ertenl [Turquie] ; Ali Akdo An [Turquie] | Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience |
| 000598 (2020) |
Angelo Fassio [Italie] ; Giovanni Adami [Italie] ; Alessandro Giollo [Italie] ; Ombretta Viapiana [Italie] ; Nazzarena Malavolta [Italie] ; Gianantonio Saviola [Italie] ; Roberto Bortolotti [Italie] ; Luca Idolazzi [Italie] ; Francesco Bertoldo [Italie] ; Maurizio Rossini [Italie] ; Davide Gatti [Italie] | Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study. |
| 000614 (2020) |
Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud] | 1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis |
